| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
One-year outcomes in survivors of the acute respiratory distress syndrome.
|
N Engl J Med
|
2003
|
11.77
|
|
2
|
Functional disability 5 years after acute respiratory distress syndrome.
|
N Engl J Med
|
2011
|
9.96
|
|
3
|
Exemestane for breast-cancer prevention in postmenopausal women.
|
N Engl J Med
|
2011
|
8.19
|
|
4
|
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary.
|
CMAJ
|
2010
|
6.37
|
|
5
|
Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research.
|
J Bone Miner Res
|
2010
|
6.00
|
|
6
|
Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.
|
J Bone Miner Res
|
2013
|
5.76
|
|
7
|
Impact of androgen deprivation therapy on cardiovascular disease and diabetes.
|
J Clin Oncol
|
2009
|
4.07
|
|
8
|
Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus.
|
J Bone Miner Res
|
2015
|
2.74
|
|
9
|
Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate.
|
J Bone Miner Res
|
2010
|
2.37
|
|
10
|
Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer.
|
J Clin Oncol
|
2014
|
2.25
|
|
11
|
Sex differences in stroke care and outcomes: results from the Registry of the Canadian Stroke Network.
|
Stroke
|
2005
|
2.08
|
|
12
|
Well-being in informal caregivers of survivors of acute respiratory distress syndrome.
|
Crit Care Med
|
2006
|
1.89
|
|
13
|
Fracture types and risk factors in men with prostate cancer on androgen deprivation therapy: a matched cohort study of 19,079 men.
|
J Urol
|
2010
|
1.87
|
|
14
|
Effectiveness and cost-effectiveness of blood pressure screening in adolescents in the United States.
|
J Pediatr
|
2010
|
1.76
|
|
15
|
Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays.
|
Can Fam Physician
|
2014
|
1.63
|
|
16
|
Bone disease in thalassemia: a frequent and still unresolved problem.
|
J Bone Miner Res
|
2009
|
1.61
|
|
17
|
Lifestyle interference and emotional distress in family caregivers of advanced cancer patients.
|
Cancer
|
2002
|
1.51
|
|
18
|
Male and non-English-speaking patients with fracture have poorer knowledge of osteoporosis.
|
J Bone Joint Surg Am
|
2011
|
1.47
|
|
19
|
Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: a randomized trial.
|
J Clin Endocrinol Metab
|
2013
|
1.21
|
|
20
|
Hormone replacement therapy for the primary prevention of chronic diseases: recommendation statement from the Canadian Task Force on Preventive Health Care.
|
CMAJ
|
2004
|
1.19
|
|
21
|
Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America.
|
Br J Haematol
|
2009
|
1.15
|
|
22
|
Osteoporosis Canada 2010 guidelines for the assessment of fracture risk.
|
Can Assoc Radiol J
|
2011
|
1.11
|
|
23
|
Voices of South Asian women: immigration and mental health.
|
Women Health
|
2004
|
1.04
|
|
24
|
Effects of the steroidal aromatase inhibitor exemestane and the nonsteroidal aromatase inhibitor letrozole on bone and lipid metabolism in ovariectomized rats.
|
Clin Cancer Res
|
2004
|
1.02
|
|
25
|
Effect of 12 months of whole-body vibration therapy on bone density and structure in postmenopausal women: a randomized trial.
|
Ann Intern Med
|
2011
|
1.01
|
|
26
|
Self-reported symptoms of depression and memory dysfunction in survivors of ARDS.
|
Chest
|
2009
|
1.01
|
|
27
|
Reproducibility of DXA estimations of body fat in HIV lipodystrophy: implications for clinical research.
|
J Clin Densitom
|
2005
|
1.00
|
|
28
|
Screening for osteoporosis in men receiving androgen deprivation therapy.
|
JAMA
|
2012
|
0.98
|
|
29
|
Bone mineral density predicts fractures in chronic kidney disease.
|
J Bone Miner Res
|
2015
|
0.98
|
|
30
|
Self-reported depressive symptoms and memory complaints in survivors five years after ARDS.
|
Chest
|
2011
|
0.96
|
|
31
|
Stroke survivor depressive symptoms are associated with family caregiver depression during the first 2 years poststroke.
|
Stroke
|
2010
|
0.95
|
|
32
|
A scoping review of strategies for the prevention of hip fracture in elderly nursing home residents.
|
PLoS One
|
2010
|
0.95
|
|
33
|
Effects of vitamin E on bone turnover markers among US postmenopausal women.
|
J Bone Miner Res
|
2012
|
0.94
|
|
34
|
Risedronate slows or partly reverses cortical and trabecular microarchitectural deterioration in postmenopausal women.
|
J Bone Miner Res
|
2014
|
0.93
|
|
35
|
Stroke survivors' behavioral and psychologic symptoms are associated with informal caregivers' experiences of depression.
|
Arch Phys Med Rehabil
|
2006
|
0.92
|
|
36
|
Prevention and management of osteoporosis in men receiving androgen deprivation therapy: a survey of urologists and radiation oncologists.
|
Urology
|
2006
|
0.90
|
|
37
|
Management of decreased bone mineral density in men starting androgen-deprivation therapy for prostate cancer.
|
BJU Int
|
2008
|
0.88
|
|
38
|
A prospective study of body fat redistribution, lipid, and glucose parameters in HIV-infected patients initiating combination antiretroviral therapy.
|
HIV Clin Trials
|
2008
|
0.86
|
|
39
|
Unusual Femur Stress Fractures in Children With Osteogenesis Imperfecta and Intramedullary Rods on Long-term Intravenous Pamidronate Therapy.
|
J Pediatr Orthop
|
2016
|
0.86
|
|
40
|
RANKL inhibition with denosumab does not influence 3-year progression of aortic calcification or incidence of adverse cardiovascular events in postmenopausal women with osteoporosis and high cardiovascular risk.
|
J Bone Miner Res
|
2014
|
0.85
|
|
41
|
Vitamin K and bone health.
|
J Clin Densitom
|
2013
|
0.83
|
|
42
|
Association between the Healthy Eating Index and bone turnover markers in US postmenopausal women aged ≥45 y.
|
Am J Clin Nutr
|
2011
|
0.83
|
|
43
|
Isoflavones with supplemental calcium provide greater protection against the loss of bone mass and strength after ovariectomy compared to isoflavones alone.
|
Bone
|
2003
|
0.83
|
|
44
|
Bone loss with exemestane: Is the jury still out?
|
J Clin Oncol
|
2005
|
0.82
|
|
45
|
The effects of atamestane and toremifene alone and in combination compared with letrozole on bone, serum lipids and the uterus in an ovariectomized rat model.
|
Breast Cancer Res Treat
|
2006
|
0.82
|
|
46
|
What makes family caregivers happy during the first 2 years post stroke?
|
Stroke
|
2014
|
0.81
|
|
47
|
Biomechanical bone strength and bone mass in young male and female rats fed a fish oil diet.
|
Prostaglandins Leukot Essent Fatty Acids
|
2003
|
0.81
|
|
48
|
Effect of whole-body vibration on calcaneal quantitative ultrasound measurements in postmenopausal women: a randomized controlled trial.
|
Calcif Tissue Int
|
2014
|
0.81
|
|
49
|
Validation of a calcium assessment tool in postmenopausal Canadian women.
|
Maturitas
|
2011
|
0.80
|
|
50
|
A community-based intervention to increase screening mammography among disadvantaged women at an inner-city drop-in center.
|
Women Health
|
2005
|
0.80
|
|
51
|
Factor structure and reliability of the brain impairment behavior scale.
|
J Neurosci Nurs
|
2008
|
0.80
|
|
52
|
Osteoporosis in primary biliary cirrhosis: a randomized trial of the efficacy and feasibility of estrogen/progestin.
|
Dig Dis Sci
|
2006
|
0.78
|
|
53
|
Relationship among MRTA, DXA, and QUS.
|
J Clin Densitom
|
2004
|
0.78
|
|
54
|
Effect of odanacatib on BMD and fractures: estimates from Bayesian univariate and bivariate meta-analyses.
|
J Clin Endocrinol Metab
|
2014
|
0.78
|
|
55
|
Vitamin K and musculoskeletal health in postmenopausal women.
|
Mol Nutr Food Res
|
2014
|
0.78
|
|
56
|
Raloxifene and colorectal cancer.
|
J Womens Health (Larchmt)
|
2005
|
0.78
|
|
57
|
Randomized clinical trial of the Timing it Right Stroke Family Support Program: research protocol.
|
BMC Health Serv Res
|
2014
|
0.78
|
|
58
|
Ten-year absolute fracture risk and hip bone strength in Canadian women with systemic lupus erythematosus.
|
J Rheumatol
|
2012
|
0.78
|
|
59
|
Odanacatib for the treatment of osteoporosis.
|
Expert Opin Pharmacother
|
2015
|
0.77
|
|
60
|
Bone-density testing interval and transition to osteoporosis.
|
N Engl J Med
|
2012
|
0.77
|
|
61
|
Population mortality during the outbreak of Severe Acute Respiratory Syndrome in Toronto.
|
BMC Public Health
|
2007
|
0.75
|
|
62
|
ACP Journal Club. In recently postmenopausal women, HRT reduced a composite of death, MI, or heart failure at 10 years.
|
Ann Intern Med
|
2013
|
0.75
|
|
63
|
The selective estrogen receptor modulator SCH 57068 prevents bone loss, reduces serum cholesterol and blocks estrogen-induced uterine hypertrophy in ovariectomized rats.
|
J Steroid Biochem Mol Biol
|
2004
|
0.75
|
|
64
|
The choice of a noninformative prior on between-study variance strongly affects predictions of future treatment effect.
|
Med Decis Making
|
2012
|
0.75
|
|
65
|
Portrayal of female physicians in cardiovascular advertisements.
|
Can J Cardiol
|
2004
|
0.75
|
|
66
|
Comparison of cortical bone measurements between pQCT and HR-pQCT.
|
J Clin Densitom
|
2012
|
0.75
|
|
67
|
Gender bias in cardiovascular advertisements.
|
J Eval Clin Pract
|
2004
|
0.75
|
|
68
|
Exploring Fear of Falling and Exercise Self-Efficacy in Older Women With Vertebral Fractures.
|
J Aging Phys Act
|
2020
|
0.75
|